(Press-News.org) The use of tobacco cessation medication in a population may lead to reduced hospital admissions for heart attacks and for coronary atherosclerosis within the two years after use according to a study by Thomas Land and colleagues from the Massachusetts Tobacco Cessation and Prevention Program, Massachusetts General Hospital and Harvard Medical School Boston, USA, and published in this week's PLoS Medicine. The study found no reduction in hospitalizations for other diseases, in the same two year period.
In July 2006, the Massachusetts Medicaid program (MassHealth) adopted comprehensive coverage of tobacco cessation medications. By the end of 2008, more than 75,000 MassHealth subscribers had used the tobacco cessation medication benefit and smoking prevalence among subscribers had declined by approximately 10%. In this study, the authors analysed MassHealth claims data to see if use of tobacco cessation medications had reduced hospital admissions for tobacco-related diseases.
After adjusting for other factors that might have affected hospitalization, such as influenza outbreaks, the authors found that among MassHealth beneficiaries, the annual rate of hospital admissions for people with heart attacks was 46% lower after use of tobacco cessation medications. In addition, there was a 49% annual decline in admissions for people with coronary atherosclerosis—another smoking-related disease. Studies show that hospitalizations for coronary heart disease are among the first diagnostic groups to show a decrease following smoking cessation, while diagnoses for cancers and smoking-related lung diseases typically improve beyond the two year time frame of this study. Accordingly, this study found no significant changes in hospital admission rates for people with lung diseases associated with smoking, such as asthma, pneumonia, and chronic airway obstruction. However, these findings cannot show if the reduced claims for hospital admissions were associated with a reduction in smoking, because smoking cessation was not recorded by MassHealth.
The results of this study suggest that removing financial barriers to the use of smoking cessation medications has the potential to produce short-term decreases in the use of hospital services that could outweigh the costs of comprehensive tobacco cessation medication benefits. However, as these findings might be unique to Massachusetts, similar studies need to be done in other US states to see whether the clinical benefits of tobacco cessation medication found in this study, can be repeated.
The authors conclude: "For low-income smokers, removing the barriers to the use of smoking cessation pharmacotherapy has the potential to decrease short-term utilization of hospital services."
INFORMATION:
Funding: The U.S. Centers for Disease Control and Prevention (CDC) has supported this work under the CDC Grant/Cooperative Agreement Number U58/CCU122821. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: In the past 5 years, NAR's institution has received research grant funding from Pfizer and Nabi Biopharmaceuticals for the study of investigational and/or marketed smoking cessation products. NAR has consulted for Pfizer and Free & Clear. NAR does not accept payment for consultation and has not for the past two years.
Citation: Land T, Rigotti NA, Levy DE, Paskowsky M, Warner D, et al. (2010) A Longitudinal Study of Medicaid Coverage for Tobacco Dependence Treatments in Massachusetts and Associated Decreases in Hospitalizations for Cardiovascular Disease. PLoS Med 7(12): e1000375. doi:10.1371/journal.pmed.1000375
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000375
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-12-land.pdf
CONTACT:
Nancy A. Rigotti, MD
Professor of Medicine, Harvard Medical School
Associate Chief, General Medicine Division, MGH
Director, Tobacco Research & Treatment Center, MGH
Director, Office of Women's Careers, MGH
617-724-4709 (assistant)
617-724-3548 (direct line/voice mail)
617-724-6774 (fax)
Tobacco cessation medication may reduce hospitalization for heart attacks
2010-12-08
ELSE PRESS RELEASES FROM THIS DATE:
Second-hand smoke increases risk of invasive meningococcal disease in children
2010-12-08
Second-hand smoke increases risk of invasive meningococcal disease in children
Children exposed to second-hand smoke are more likely to get invasive meningococcal disease than children who are not exposed, reports a study from Chien-Chang Lee at the Harvard School of Public Health (Boston, USA) and colleagues published in this week's PLoS Medicine. The authors also found a possible association of second-hand smoke exposure with invasive pneumococcal disease and Haemophilus influenzae type b.
By reviewing and analysing published studies (30 case-control and 12 cross-sectional ...
Including smoking cessation program with treatment for PTSD shows higher rate of quitting
2010-12-08
Among smokers with military-related posttraumatic stress disorder (PTSD), integrating smoking cessation treatment with mental health care for PTSD resulted in higher rates of prolonged smoking abstinence, compared to referral for assistance with quitting smoking, according to a study in the December 8 issue of JAMA.
Nicotine dependence is more common among individuals with mental illness. "Posttraumatic stress disorder, a prevalent mental disorder, is highly associated with smoking (45 percent) and unsuccessful quit attempts. Individuals with PTSD smoke more heavily than ...
Detection of cardiac biomarker associated with structural heart disease, increased risk of death
2010-12-08
With the use of a highly sensitive test, detection of the blood biomarker cardiac troponin T, a cardiac-specific protein, is associated with structural heart disease and an increased risk of all-cause death, according to a study in the December 8 issue of JAMA.
Cardiac troponin T (cTnT) is a preferred biomarker for the diagnosis of heart attack, and increasingly it has been recognized that elevated troponin levels may be detected in several chronic disease states, including coronary artery disease (CAD), heart failure, and chronic kidney disease (CKD). Some research has ...
Use of low-dose aspirin associated with improved performance of test for detecting colorectal cancer
2010-12-08
Use of low-dose aspirin prior to a newer type of fecal occult blood test is associated with a higher sensitivity for detecting advanced colorectal tumors, compared to no aspirin use, according to a study in the December 8 issue of JAMA.
"Screening for colorectal cancer (CRC) and its precursors by fecal occult blood tests (FOBTs), which has been shown to reduce CRC incidence and mortality in randomized trials, is widely recommended and applied in an increasing number of countries. Screening is mostly done in age groups in which use of low-dose aspirin for primary or secondary ...
New blood test could detect heart disease in people with no symptoms
2010-12-08
DALLAS – Dec. 7, 2010 – A more sensitive version of a blood test typically used to confirm that someone is having a heart attack could indicate whether a seemingly healthy, middle-aged person has unrecognized heart disease and an increased risk of dying, UT Southwestern Medical Center researchers have found.
In a study available online and in the Dec. 8 print issue of the Journal of the American Medical Association, researchers found that a new, highly sensitive test for a protein called cardiac troponin T (cTnT) could detect the protein in about 25 percent of blood ...
Melanopsin looks on the bright side of life
2010-12-08
LA JOLLA, CA-Better known as the light sensor that sets the body's biological clock, melanopsin also plays an important role in vision: Via its messengers-so-called melanopsin-expressing retinal ganglion cells, or mRGCs-it forwards information about the brightness of incoming light directly to conventional visual centers in the brain, reports an international collaboration of scientists in this week's issue of PLoS Biology.
The findings reveal a new role for mRGCs during image-forming vision and suggest that these cells could make a significant contribution to assessing ...
Music relieves stress of assisted breathing
2010-12-08
Patients who need assistance to breathe through mechanical ventilation may benefit from listening to music, a new review published in The Cochrane Library shows. The researchers found that music listening may relax patients, potentially resulting in fewer complications.
Mechanical ventilation often causes major distress and anxiety in patients. The sensation of breathlessness, frequent suctioning, inability to talk, uncertainty regarding surroundings or condition, discomfort, isolation from others, and fear all contribute to high levels of anxiety. Medications administered ...
Desensitisation approaches effective against hayfever-like allergies
2010-12-08
Immunotherapy given as pills or drops under the tongue is a safe and effective way to treat hayfever-like allergies caused by pollen and dust mites, according to a new Cochrane Systematic Review. The researchers say the approach is an attractive alternative to immunotherapy injections in children.
Common treatments for hayfever-like symptoms caused by allergies include antihistamines and nasal corticosteroids. If these prove unsuccessful, doctors may recommend immunotherapy, a desensitisation approach that involves exposing patients to increasing doses of an allergen. ...
Vitamin supplements reduce deaths caused by measles and diarrhea
2010-12-08
Vitamin A supplements are still an effective way to reduce childhood death and disease. A new study by Cochrane researchers strongly endorses the continuation of vitamin A supplementation programmes, which reduce the incidence of measles and diarrhoea and ultimately save lives.
Vitamin A deficiency is a common problem in low and middle income countries. People whose diets do not include enough of the vitamin may have impaired body functions, and be more susceptible to blindness, infection and early death. The World Health Organization (WHO) recommends vitamin A supplements ...
John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
2010-12-08
HACKENSACK, N.J. (December 7, 2010 at 7:30am) — The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings presented at the annual meeting of the American Society of Hematology (ASH) taking place December 4-7, 2010 in Orlando, Florida. The ASH meeting is the world's leading scientific gathering of hematologists and hematology researchers.
Research highlights from the 40 abstracts from the John Theurer Cancer Center include a comparison of treatment with stem cell transplantation versus continued combination drug ...